Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19
Clinical trial NCT04421534 · UNKNOWN
Trial details
- NCT number
- NCT04421534
- Sponsor
- Cairo University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2020-09-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.